A day before its second annual Vaccines Day, Moderna has posted an update on its crown jewel, including a 6-month look at the Covid-19 shot and new preclinical data that suggest its booster candidates stand a fighting chance against new variants.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,